AJOB Volume 26, Issue 2
Related posts
Evaluating the Price of Oregon’s Psilocybin Services: Finding the Right Comparison
Oregon’s psilocybin services are often described as quite expensive in both media coverage and academic discussions. However, when making this claim, we should ask: expensive compared to what? Whether or not psilocybin services are considered too expensive may, in fact, depend in large part on whether their use is being thought of as healthcare, a luxury experience, a quasi-therapeutic […]
Can Researchers Experience Moral Distress?
In the context of healthcare, moral distress has traditionally described the emotional and psychological distress healthcare providers experience when they are prevented from acting in the way they feel is most ethical or just. Their moral agency is typically constrained by institutional policies, pressures, or a lack of resources. NPR, for instance, recently reported on […]
How Should Adolescents Be Included in Clinical Psychedelic Research?
Psychedelic-assisted therapy will soon be approved for adults. If the history of adult psychiatric drugs is any guide, adolescents will not be far behind — which makes the question of how they should be included in research an urgent one. That question has typically been framed through the lens of autonomy, and specifically through the […]
In Every Country I Practiced, I Was a Doctor — Until America
In American hospitals, beneath the noise of day-to-day clinical work, a quieter, more insidious shift has taken place—a linguistic one that is eroding the physician’s identity. After two decades of practice across three continents, I have been called many things: healer, doctor, advisor, confidant, and student. Only in the United States have I been routinely […]